The ability to predict drug interactions mediated by active drug transport systems can help optimise pharmacotherapy


    loading  Checking for direct PDF access through Ovid

Abstract

Although most drug interactions result from inhibition or induction of cytochrome P450 isozymes, recent evidence suggests that active transmembrane drug transporting systems also have a role in pharmacokinetic drug interactions. P-glycoprotein is involved in cellular efflux of drugs, while human organic anion-transporting polypeptide is involved in cellular influx. The bioavailability of substrate drugs can be affected by other drugs or food that act as inhibitors or inducers of these systems

    loading  Loading Related Articles